Cargando…
Identification of a Novel Pseudo‐Natural Product Type IV IDO1 Inhibitor Chemotype
Natural product (NP)‐inspired design principles provide invaluable guidance for bioactive compound discovery. Pseudo‐natural products (PNPs) are de novo combinations of NP fragments to target biologically relevant chemical space not covered by NPs. We describe the design and synthesis of apoxidoles,...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804781/ https://www.ncbi.nlm.nih.gov/pubmed/35959923 http://dx.doi.org/10.1002/anie.202209374 |
_version_ | 1784862189808517120 |
---|---|
author | Davies, Caitlin Dötsch, Lara Ciulla, Maria Gessica Hennes, Elisabeth Yoshida, Kei Gasper, Raphael Scheel, Rebecca Sievers, Sonja Strohmann, Carsten Kumar, Kamal Ziegler, Slava Waldmann, Herbert |
author_facet | Davies, Caitlin Dötsch, Lara Ciulla, Maria Gessica Hennes, Elisabeth Yoshida, Kei Gasper, Raphael Scheel, Rebecca Sievers, Sonja Strohmann, Carsten Kumar, Kamal Ziegler, Slava Waldmann, Herbert |
author_sort | Davies, Caitlin |
collection | PubMed |
description | Natural product (NP)‐inspired design principles provide invaluable guidance for bioactive compound discovery. Pseudo‐natural products (PNPs) are de novo combinations of NP fragments to target biologically relevant chemical space not covered by NPs. We describe the design and synthesis of apoxidoles, a novel pseudo‐NP class, whereby indole‐ and tetrahydropyridine fragments are linked in monopodal connectivity not found in nature. Apoxidoles are efficiently accessible by an enantioselective [4+2] annulation reaction. Biological evaluation revealed that apoxidoles define a new potent type IV inhibitor chemotype of indoleamine 2,3‐dioxygenase 1 (IDO1), a heme‐containing enzyme considered a target for the treatment of neurodegeneration, autoimmunity and cancer. Apoxidoles target apo‐IDO1, prevent heme binding and induce unique amino acid positioning as revealed by crystal structure analysis. Novel type IV apo‐IDO1 inhibitors are in high demand, and apoxidoles may provide new opportunities for chemical biology and medicinal chemistry research. |
format | Online Article Text |
id | pubmed-9804781 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98047812023-01-06 Identification of a Novel Pseudo‐Natural Product Type IV IDO1 Inhibitor Chemotype Davies, Caitlin Dötsch, Lara Ciulla, Maria Gessica Hennes, Elisabeth Yoshida, Kei Gasper, Raphael Scheel, Rebecca Sievers, Sonja Strohmann, Carsten Kumar, Kamal Ziegler, Slava Waldmann, Herbert Angew Chem Int Ed Engl Research Articles Natural product (NP)‐inspired design principles provide invaluable guidance for bioactive compound discovery. Pseudo‐natural products (PNPs) are de novo combinations of NP fragments to target biologically relevant chemical space not covered by NPs. We describe the design and synthesis of apoxidoles, a novel pseudo‐NP class, whereby indole‐ and tetrahydropyridine fragments are linked in monopodal connectivity not found in nature. Apoxidoles are efficiently accessible by an enantioselective [4+2] annulation reaction. Biological evaluation revealed that apoxidoles define a new potent type IV inhibitor chemotype of indoleamine 2,3‐dioxygenase 1 (IDO1), a heme‐containing enzyme considered a target for the treatment of neurodegeneration, autoimmunity and cancer. Apoxidoles target apo‐IDO1, prevent heme binding and induce unique amino acid positioning as revealed by crystal structure analysis. Novel type IV apo‐IDO1 inhibitors are in high demand, and apoxidoles may provide new opportunities for chemical biology and medicinal chemistry research. John Wiley and Sons Inc. 2022-08-29 2022-10-04 /pmc/articles/PMC9804781/ /pubmed/35959923 http://dx.doi.org/10.1002/anie.202209374 Text en © 2022 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Davies, Caitlin Dötsch, Lara Ciulla, Maria Gessica Hennes, Elisabeth Yoshida, Kei Gasper, Raphael Scheel, Rebecca Sievers, Sonja Strohmann, Carsten Kumar, Kamal Ziegler, Slava Waldmann, Herbert Identification of a Novel Pseudo‐Natural Product Type IV IDO1 Inhibitor Chemotype |
title | Identification of a Novel Pseudo‐Natural Product Type IV IDO1 Inhibitor Chemotype |
title_full | Identification of a Novel Pseudo‐Natural Product Type IV IDO1 Inhibitor Chemotype |
title_fullStr | Identification of a Novel Pseudo‐Natural Product Type IV IDO1 Inhibitor Chemotype |
title_full_unstemmed | Identification of a Novel Pseudo‐Natural Product Type IV IDO1 Inhibitor Chemotype |
title_short | Identification of a Novel Pseudo‐Natural Product Type IV IDO1 Inhibitor Chemotype |
title_sort | identification of a novel pseudo‐natural product type iv ido1 inhibitor chemotype |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804781/ https://www.ncbi.nlm.nih.gov/pubmed/35959923 http://dx.doi.org/10.1002/anie.202209374 |
work_keys_str_mv | AT daviescaitlin identificationofanovelpseudonaturalproducttypeivido1inhibitorchemotype AT dotschlara identificationofanovelpseudonaturalproducttypeivido1inhibitorchemotype AT ciullamariagessica identificationofanovelpseudonaturalproducttypeivido1inhibitorchemotype AT henneselisabeth identificationofanovelpseudonaturalproducttypeivido1inhibitorchemotype AT yoshidakei identificationofanovelpseudonaturalproducttypeivido1inhibitorchemotype AT gasperraphael identificationofanovelpseudonaturalproducttypeivido1inhibitorchemotype AT scheelrebecca identificationofanovelpseudonaturalproducttypeivido1inhibitorchemotype AT sieverssonja identificationofanovelpseudonaturalproducttypeivido1inhibitorchemotype AT strohmanncarsten identificationofanovelpseudonaturalproducttypeivido1inhibitorchemotype AT kumarkamal identificationofanovelpseudonaturalproducttypeivido1inhibitorchemotype AT zieglerslava identificationofanovelpseudonaturalproducttypeivido1inhibitorchemotype AT waldmannherbert identificationofanovelpseudonaturalproducttypeivido1inhibitorchemotype |